What grades are available for this product
Drug-specific variables that may affect half-life Drug formulation (ie, modified or controlled release preparations extend half-life) How the drug behaves in the body (ie, zero-order, first-order, or multi-compartmental pharmacokinetics) How the drug is administered (half-life may be different with IV administration, compared to intranasal or oral administration) How the drug is cleared from the body (eg, kidneys, liver, lungs) If the drug accumulates in fat or other types of tissue If the drug binds to proteins or not Presence of metabolites or other drugs that may interact Properties of the drug, including molecule size, charge, and pKa The volume of distribution of a drug Other variables, such as if the drug is actively transported, is self-induced, or has saturation pharmacokinetics
569 Their chemical structure, dosage form, and administration route are the main determinants of their absorption, distribution, metabolism, and excretion, thereby affecting their efficacy and safety
For example, that stress inhibits the pathway that leads to production of BDNF [164] and that following dietary restriction upregulation of BDNF is required for the antidepressant treatment-induced increase in survival of newborn granule cells [165]
We will cover the optimal choices for every common vial size in the sections below
For instance, hydroxycobalamin is stored in the body longer than cyanocobalamin, reducing the need for frequent injections